Trial reportBMC anesthesiology2025
Effect of liposomal bupivacaine for the suprascapular nerve combined with axillary nerve block on postoperative analgesia in patients undergoing shoulder surgery: a randomized, observer-blinded trial.
Trial report in BMC anesthesiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThis study was conducted to explore whether liposomal bupivacaine for the suprascapular nerve combined with axillary nerve block can provide noninferior postoperative analgesia and reduced hemidiaphragmatic paralysis (HDP) versus traditional interscalene brachial plexus block in patients undergoing arthroscopic shoulder surgery.
methodsPatients were divided into a suprascapular nerve and axillary nerve block group (SSANB group) and an interspinal brachial plexus block group (IBB group) via a random number table. The local anesthetic used was a mixture of 1.33% liposomal bupivacaine and 0.5% levobupivacaine hydrochloride injected in equal volume. The primary outcome measures included resting numerical rating scale (NRS) scores at 72 h after surgery and the incidence of HDP 30 min after block.
resultsFinally, 48 patients were included. The incidence rates of HDP in the SA and IB groups were 4% (1/25) and 78.3% (18/23), respectively, with statistical significance (P < 0.001). The motor block duration in group IB was significantly longer than that in group SA (30.57 ± 17.13 vs. 0.88 ± 4.40 h, P < 0.001). There were no significant differences in the NRS score at rest after surgery, opioid consumption, satisfaction with analgesia, sensory block duration, perioperative adverse effects, or neurological complications between the two groups (all P > 0.05).
conclusionsLiposomal bupivacaine for the suprascapular nerve combined with axillary nerve block can provide long-term postoperative analgesia that is noninferior to traditional interscalene brachial plexus block and results in fewer HDP occurrences in patients undergoing arthroscopic shoulder surgery.
trial registrationThis study was registered at www.chictr.org.cn on June 28, 2024 (registration number: ChiCTR2400086331).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.